Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001809726-21-000001
Filing Date
2021-07-14
Accepted
2021-07-14 12:42:55
Documents
1
Effectiveness Date
2021-07-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8311
  Complete submission text file 0001809726-21-000001.txt   9349
Mailing Address 299 PAVONIA AVENUE 3-8 JERSEY CITY NJ 07302
Business Address 299 PAVONIA AVENUE 3-8 JERSEY CITY NJ 07302 201-344-7638
Claris Biotherapeutics, Inc. (Filer) CIK: 0001809726 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-365789 | Film No.: 211089745